143 related articles for article (PubMed ID: 28906311)
1. Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
Al-Harbi NM; Bin Judia SS; Mishra KN; Shoukri MM; Alsbeih GA
Int J Gynecol Cancer; 2017 Nov; 27(9):1949-1956. PubMed ID: 28906311
[TBL] [Abstract][Full Text] [Related]
2. HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia.
Alsbeih G; Al-Harbi N; El-Sebaie M; Al-Badawi I
Infect Agent Cancer; 2013 May; 8(1):15. PubMed ID: 23642098
[TBL] [Abstract][Full Text] [Related]
3. Involvement of single-nucleotide polymorphisms in predisposition to head and neck cancer in Saudi Arabia.
Al-Hadyan KS; Al-Harbi NM; Al-Qahtani SS; Alsbeih GA
Genet Test Mol Biomarkers; 2012 Feb; 16(2):95-101. PubMed ID: 21877955
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in DNA repair genes and their association with cervical cancer.
Abbas M; Srivastava K; Imran M; Banerjee M
Br J Biomed Sci; 2019 Jul; 76(3):117-121. PubMed ID: 30870085
[No Abstract] [Full Text] [Related]
5. Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population.
Charles MR; Raza ST; Sharma R; Pratap P; Eba A; Singh M
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2061-2065. PubMed ID: 32711433
[TBL] [Abstract][Full Text] [Related]
6. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes.
Alsbeih G; Al-Harbi N; Al-Hadyan K; El-Sebaie M; Al-Rajhi N
Radiat Res; 2010 Apr; 173(4):505-11. PubMed ID: 20334523
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.
Raabe A; Derda K; Reuther S; Szymczak S; Borgmann K; Hoeller U; Ziegler A; Petersen C; Dikomey E
Radiat Oncol; 2012 Apr; 7():65. PubMed ID: 22537351
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma.
Roszak A; Lianeri M; Jagodzinski PP
Int J Biol Markers; 2011; 26(4):216-20. PubMed ID: 21928248
[TBL] [Abstract][Full Text] [Related]
9. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
10. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
Liu GC; Zhou YF; Su XC; Zhang J
BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
[TBL] [Abstract][Full Text] [Related]
11. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
12. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women.
Barbisan G; Pérez LO; Difranza L; Fernández CJ; Ciancio NE; Golijow CD
Eur J Gynaecol Oncol; 2011; 32(3):274-9. PubMed ID: 21797115
[TBL] [Abstract][Full Text] [Related]
14. Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.
Priyadarshi S; Ray CS; Panda KC; Desai A; Nayak SR; Biswal NC; Ramchander PV
J Bone Miner Res; 2013 Dec; 28(12):2490-7. PubMed ID: 23703862
[TBL] [Abstract][Full Text] [Related]
15. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
[TBL] [Abstract][Full Text] [Related]
16. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity.
Zschenker O; Raabe A; Boeckelmann IK; Borstelmann S; Szymczak S; Wellek S; Rades D; Hoeller U; Ziegler A; Dikomey E; Borgmann K
Radiother Oncol; 2010 Oct; 97(1):26-32. PubMed ID: 20170971
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between X-ray repair cross-complementing group 1 gene polymorphisms and the susceptibility to colorectal cancer in a Malaysian cohort.
Lau TP; Lian LH; Cheah PL; Looi LM; Roslani AC; Goh KL; Lee PC; Chua KH
Eur J Cancer Prev; 2017 Nov; 26(6):506-510. PubMed ID: 28059856
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
[TBL] [Abstract][Full Text] [Related]
20. DNA base excision repair genes variants rs25487 (X-ray repair cross-complementing 1) and rs1052133 (human 8-oxoguanine glycosylase 1) with susceptibility to ovarian cancer in the population of the Jammu region, India.
Verma S; Sharma V; Nagpal A; Bhat A; Bhat GR; Shah R; Wakhloo A; Suri J; Abrol D; Kaul S; Bhat A; Verma V; Kumar R
J Cancer Res Ther; 2019; 15(6):1270-1275. PubMed ID: 31898659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
